Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery

Area of Science:

• Orthopedics
• Hematology
• Surgical Complications

Background:

• Sickle cell disease (SCD) is a genetic blood disorder with significant musculoskeletal manifestations.
• Common complications include osteonecrosis of major joints, particularly the hip, and bone infarcts.
• These complications lead to pain, reduced function, and diminished quality of life for patients.

Purpose of the Study:

• To highlight the unique challenges in surgical management of patients with SCD.
• To emphasize the increased risk of complications in SCD patients undergoing surgery.
• To advocate for a multidisciplinary approach in the surgical care of SCD patients.

Main Methods:

• This section is not applicable as the abstract does not detail specific methods.
• The abstract focuses on the clinical presentation and management considerations of SCD.

Main Results:

• SCD frequently leads to osteonecrosis and bone infarcts, causing pain and functional decline.
• Patients with SCD often require early surgical interventions like total hip arthroplasty.
• The inherent pathology of SCD presents substantial medical and surgical challenges.

Conclusions:

• Surgical care for SCD patients is complex due to disease-specific risks.
• A coordinated, multidisciplinary team approach is essential for optimal surgical outcomes in SCD.
• Early recognition and management of SCD-related musculoskeletal issues are crucial.